Advertisement

Topics

Search Results for "Neupro"

12:55 EDT 18th October 2017 | BioPortfolio

Matching Channels

None

Matching News

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Revision: 23, Authorised

Market Access Impact US [Parkinson's Disease] [Report Updated: 01072017] Prices from USD $5145

Are high cost and market access problems costing your brand market share? Are market barriers holding your brand back? According to our survey of USbased neurologists, 8 of the 11 Parkinson's disease ...

UCB Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24082017] Prices from USD $250

SummaryUCB Inc UCB, a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeu...

UCB SA UCB Medical Equipment Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryUCB SA UCB is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatme...

UCB SA UCB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryUCB SA UCB is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatme...

NewBridge Pharmaceuticals FZ LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryNewBridge Pharmaceuticals FZ LLC NewBridge Pharmaceuticals is a pharmaceutical company that offers solutions to biological, genomics, pharmaceuticals, and healthcare companies. The company offe...

NewBridge Pharmaceuticals FZ LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryNewBridge Pharmaceuticals FZ LLC NewBridge Pharmaceuticals is a specialty pharmaceutical company which offers solutions to biological, genomics, pharmaceuticals, and healthcare companies. The c...

UCB SA UCB Financial and Strategic SWOT Analysis Review [Updated: 30052017] Prices from USD $125

UCB SA UCB Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to brin...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement